Congrats to PA Hospital Brisbane on the recruitment of their first participant to BOOST-IC!👏 Great to have you on board in this important study.

Remarkable to look at COVID booster recs in different countries ATM. Everyone > 5 years in the US with an updated vaccine from CDC bit.ly/3PXiEsJ compared to all over 75 and adults with severe immunocompromise from ATAGI Australian Dept of Health, Disability and Ageing bit.ly/3tdVCEX 😯💉

XBB.1.5 vaccines are getting approved. ARTG updates today for Pfizer Inc. XBB.1.5 monovalent bit.ly/3tnVNO2 😯💉

Onwards and upwards for BOOST-IC. Huge thanks to all of our participants and sites 🙏. And now XBB.1.5 waiting in the wings....... 💉🧚

🥵 off the press!! New COVID vaccine recs from ATAGI. health.gov.au/news/atagi-rec…

In recent weeks there has been a rapid increase in people with COVID in hospital. Learn how to protect those most at risk of severe disease. go.vic.gov.au/49aqs1x

COVID-19 XBB.1.5 vaccines now being administered in BOOST-IC 💉 Congrats to the first sites to achieve this The Alfred Monash Health PA Hospital Brisbane 🙏 Amazing work from these sites and all sites enrolling 👏👏👏

Now hiring to a project officer role for the PROPHECY study. Large MRFF funded clinical and scientific collaboration studying COVID vaccine responses in high risk populations.PROPHECY Study livehire.com/job/alfredheal… monash.edu/medicine/proph…

Amazing day BOOST-IC 👋👋 260 people enrolled!! Congratulations boostic.org.au What a team of investigators and participants TSANZ Australasian Leukaemia & Lymphoma Group (ALLG) ASHM Monash University

In follow up to our first study bit.ly/3OiBxVy, we report the final analysis from the CIBMTR BMT CTN study of early (<4 mo) vs late (4-12 mo) SARS-CoV-2 vaccination after #HCT and #CART in 466 participants. ASTCT @DrMiguelPerales Jeff Auletta medrxiv.org/content/10.110…

XBB.1.5 monovalent vaccine effectiveness against hospitalisation? 2 papers out in The Lancet Infectious Diseases from @C_HHansen bit.ly/42J2aZK and Eurosurveillance from @hvwerkhoven bit.ly/3whBm6K 70-75% effectiveness in those > 60 yrs old. Get boosted!

274 people are currently participating in BOOST-IC across 11 sites in Australia, trying to understand and fine tune #COVID19 vaccine boosting for immunocompromised people. With mounting evidence for benefit, will you or someone you know be next?

Thanks for highlighting this Eric Topol need to watch BA.2.87.1 biorxiv.org/content/10.110…

285 participants enrolled in #BOOSTIC. Don’t forget, you can keep up to date on enrollment and access information for consumers, HCWs and about our study design on the BOOST-IC website (boostic.org.au)

Great summary on Flu and other vaccines for winter from Allen Cheng Thanks Allen! bit.ly/4aEUV8c Get your Flu and COVID-19 vaccines this year💉💉Winter's coming! 🌧️🌩️

🚨BOOST-IC enrolled its 300th participant today!🚨 Well done to all our collaborators and thank you to our participants. 🥳👏🏻🎉 The Alfred Monash University TSANZ Australasian Leukaemia & Lymphoma Group (ALLG) NHMRC #MRFF ASHM

Pleased to announce the publication of the #BOOSTIC protocol paper, describing how we’re exploring the role of booster doses of COVID-19 vaccines in immunocompromised hosts! doi.org/10.1186/s13063… Dr David Griffin 🦠🧫💉 James McMahon Orla Morrissey Monash University The Alfred Michael Dymock

#OpenAccess BMC Series #Trials #statstwitter looking for the details of how we’re analysing BOOST-IC? #BOOSTIC: Statistical elements and design, lead by Michael Dymock Dr David Griffin 🦠🧫💉 James McMahon Monash University The Alfred rdcu.be/exXi8